Daventry Group, LP
- SEC CIK
- 0001823718
- Latest filing
- Aug 14, 2026
HCAT holding history
Health Catalyst, Inc. in every 13F filed by Daventry Group, LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
HCAT overviewAll 13F holders of HCATFull Q2 2026 holdings
- Shares (Q1 2025)
- 0
- Sold out in Q1 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 13
- Since Q4 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2025 | 0 | $0 | 0.0% | −2,509,480−100.0% | Sold out | Holders |
| Q4 2024 | 2,509,480 | $17.7M | 6.8% | +91,878+3.8% | Added | Holders |
| Q3 2024 | 2,417,602 | $19.7M | 7.8% | +170,549+7.6% | Added | Holders |
| Q2 2024 | 2,247,053 | $14.4M | 6.4% | +84,178+3.9% | Added | Holders |
| Q1 2024 | 2,162,875 | $16.3M | 6.5% | +242,500+12.6% | Added | Holders |
| Q4 2023 | 1,920,375 | $17.8M | 7.6% | +346,200+22.0% | Added | Holders |
| Q3 2023 | 1,574,175 | $15.9M | 10.2% | −62,936−3.8% | Reduced | Holders |
| Q2 2023 | 1,637,111 | $20.5M | 15.1% | 00.0% | Unchanged | Holders |
| Q1 2023 | 1,637,111 | $19.1M | 13.4% | +197,497+13.7% | Added | Holders |
| Q4 2022 | 1,439,614 | $15.3M | 13.2% | +587,110+68.9% | Added | Holders |
| Q3 2022 | 852,504 | $8.27M | 11.2% | 00.0% | Unchanged | Holders |
| Q2 2022 | 852,504 | $12.4M | 16.8% | +291,743+52.0% | Added | Holders |
| Q1 2022 | 560,761 | $14.7M | 15.2% | +250,353+80.7% | Added | Holders |
| Q4 2021 | 310,408 | $12.3M | 13.8% | – | No prior filing | Holders |